340 related articles for article (PubMed ID: 31329830)
1. Single-cell transcriptome-based multilayer network biomarker for predicting prognosis and therapeutic response of gliomas.
Zhang J; Guan M; Wang Q; Zhang J; Zhou T; Sun X
Brief Bioinform; 2020 May; 21(3):1080-1097. PubMed ID: 31329830
[TBL] [Abstract][Full Text] [Related]
2. Multicellular gene network analysis identifies a macrophage-related gene signature predictive of therapeutic response and prognosis of gliomas.
Sun X; Liu X; Xia M; Shao Y; Zhang XD
J Transl Med; 2019 May; 17(1):159. PubMed ID: 31097021
[TBL] [Abstract][Full Text] [Related]
3. Single cell RNA sequencing reveals differentiation related genes with drawing implications in predicting prognosis and immunotherapy response in gliomas.
Zhou Z; Wei J; Yang Z; Bao Y; Jiang W; Lu B; Wang W; Li L
Sci Rep; 2022 Feb; 12(1):1872. PubMed ID: 35115572
[TBL] [Abstract][Full Text] [Related]
4. In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.
Lvu W; Fei X; Chen C; Zhang B
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725165
[TBL] [Abstract][Full Text] [Related]
5. Systematic expression analysis of ligand-receptor pairs reveals important cell-to-cell interactions inside glioma.
Yuan D; Tao Y; Chen G; Shi T
Cell Commun Signal; 2019 May; 17(1):48. PubMed ID: 31118022
[TBL] [Abstract][Full Text] [Related]
6. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
Front Immunol; 2020; 11():603341. PubMed ID: 33363544
[TBL] [Abstract][Full Text] [Related]
7. M2 macrophage marker CHI3L2 could serve as a potential prognostic and immunological biomarker in glioma by integrated single-cell and bulk RNA-Seq analysis.
Qian W; Wang Q; Zhang C; Zhu J; Zhang Q; Luo C
J Gene Med; 2023 Sep; 25(9):e3523. PubMed ID: 37147894
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value and their clinical implication of 89-gene signature in glioma.
Shahid M; Cho KM; Nguyen MN; Choi TG; Jo YH; Aryal SN; Yoo JY; Yun HR; Lee JW; Eun YG; Lee JS; Kang I; Ha J; Yoon HJ; Kim SY; Kim SS
Oncotarget; 2016 Aug; 7(32):51237-51250. PubMed ID: 27323413
[TBL] [Abstract][Full Text] [Related]
9. Integrative analysis of bulk RNA-seq and scRNA-seq data indicates the prognostic and immunologic values of SERPINH1 in glioma.
Hou S; Chen Y; Jin C; Lin N
Environ Toxicol; 2024 Jun; 39(6):3654-3665. PubMed ID: 38506564
[TBL] [Abstract][Full Text] [Related]
10. Six Immune Associated Genes Construct Prognostic Model Evaluate Low-Grade Glioma.
Tan YQ; Li YT; Yan TF; Xu Y; Liu BH; Yang JA; Yang X; Chen QX; Zhang HB
Front Immunol; 2020; 11():606164. PubMed ID: 33408717
[TBL] [Abstract][Full Text] [Related]
11. A nuclear transport-related gene signature combined with IDH mutation and 1p/19q codeletion better predicts the prognosis of glioma patients.
Zhu Z; Lan Y; Wang L; Ge J; Wang J; Liu F; He Z; Zhang H; Luo M; Lin D; Tan Y; Xu Y; Luo T
BMC Cancer; 2020 Nov; 20(1):1072. PubMed ID: 33167941
[TBL] [Abstract][Full Text] [Related]
12. Weighted gene correlation network analysis identifies microenvironment-related genes signature as prognostic candidate for Grade II/III glioma.
Li Y; Deng G; Zhang H; Qi Y; Gao L; Tan Y; Hu P; Wang Y; Liu B; Chen Q
Aging (Albany NY); 2020 Nov; 12(21):22122-22138. PubMed ID: 33186124
[TBL] [Abstract][Full Text] [Related]
13. Novel prognostic biomarker TBC1D1 is associated with immunotherapy resistance in gliomas.
Song D; Yang Q; Li L; Wei Y; Zhang C; Du H; Ren G; Li H
Front Immunol; 2024; 15():1372113. PubMed ID: 38529286
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatic Profiling Identifies a Fatty Acid Metabolism-Related Gene Risk Signature for Malignancy, Prognosis, and Immune Phenotype of Glioma.
Qi Y; Chen D; Lu Q; Yao Y; Ji C
Dis Markers; 2019; 2019():3917040. PubMed ID: 31885736
[TBL] [Abstract][Full Text] [Related]
15. Single-Cell RNA-Sequencing in Glioma.
Johnson E; Dickerson KL; Connolly ID; Hayden Gephart M
Curr Oncol Rep; 2018 Apr; 20(5):42. PubMed ID: 29637300
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.
Maimaiti A; Wang X; Pei Y; Nuermaimaiti N; Tuersunniyazi A; Abula Y; Feng Z; Jiang L; Shi X; Kasimu M
Aging (Albany NY); 2021 Jun; 13(11):15164-15192. PubMed ID: 34081618
[TBL] [Abstract][Full Text] [Related]
17. N6-methyladenine-related genes affect biological behavior and the prognosis of glioma.
Qu S; Chen Z; Liu B; Liu J; Wang H
Cancer Med; 2021 Jan; 10(1):98-108. PubMed ID: 33264518
[TBL] [Abstract][Full Text] [Related]
18. Single-cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapy.
Ding S; Chen X; Shen K
Cancer Commun (Lond); 2020 Aug; 40(8):329-344. PubMed ID: 32654419
[TBL] [Abstract][Full Text] [Related]
19. PDIA5 is Correlated With Immune Infiltration and Predicts Poor Prognosis in Gliomas.
Zhang H; He J; Dai Z; Wang Z; Liang X; He F; Xia Z; Feng S; Cao H; Zhang L; Cheng Q
Front Immunol; 2021; 12():628966. PubMed ID: 33664747
[TBL] [Abstract][Full Text] [Related]
20. Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq.
Venteicher AS; Tirosh I; Hebert C; Yizhak K; Neftel C; Filbin MG; Hovestadt V; Escalante LE; Shaw ML; Rodman C; Gillespie SM; Dionne D; Luo CC; Ravichandran H; Mylvaganam R; Mount C; Onozato ML; Nahed BV; Wakimoto H; Curry WT; Iafrate AJ; Rivera MN; Frosch MP; Golub TR; Brastianos PK; Getz G; Patel AP; Monje M; Cahill DP; Rozenblatt-Rosen O; Louis DN; Bernstein BE; Regev A; SuvĂ ML
Science; 2017 Mar; 355(6332):. PubMed ID: 28360267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]